Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Mount Sinai Comprehensive Cancer Center
mi
from
Miami Beach, FL
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Mount Sinai Comprehensive Cancer Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
University of Hawaii Cancer Center
mi
from
Honolulu, HI
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
University of Hawaii Cancer Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
University of Kansas Cancer Center
mi
from
Westwood, KA
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
University of Kansas Cancer Center
mi
from
Westwood, KA
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Billings Clinic Cancer Center
mi
from
Billings, MT
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
New York University Langone Medical Center
mi
from
New York, NY
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
University of North Carolina Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
University of North Carolina Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Levine Cancer Institute
mi
from
Charlotte, NC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Cone Health Cancer Center
mi
from
Greensboro, NC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Cone Health Cancer Center
mi
from
Greensboro, NC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Hendersonville Hematology and Oncology at Pardee
mi
from
Hendersonville, NC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Hendersonville Hematology and Oncology at Pardee
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Rex Cancer Center UNC Healthcare
mi
from
Raleigh, NC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Rex Cancer Center UNC Healthcare
mi
from
Raleigh, NC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
St. Alexis Medical Center-Mid Dakota Clinic PC
mi
from
Bismarck, ND
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
St. Alexis Medical Center-Mid Dakota Clinic PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
University of Cincinnati Cancer Center
mi
from
Cincinnati, OH
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
University of Cincinnati Cancer Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Kaiser Permanente NW
mi
from
Portland, OR
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Kaiser Permanente NW
mi
from
Portland, OR
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Medical University of South Carolina Hollings Cancer Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
McLeod Regional Medical Center
mi
from
Florence, SC
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
McLeod Regional Medical Center
mi
from
Florence, SC
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
University of Colorado Cancer Center
mi
from
Aurora, CO
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
UMass Medical School
mi
from
Worcester, MA
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
UMass Medical School
mi
from
Worcester, MA
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  12/7/2015
Semmelweis University Department of Diagnostic Radiology and Oncotherapy
mi
from
Budapest,
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 12/7/2015
Semmelweis University Department of Diagnostic Radiology and Oncotherapy
mi
from
Budapest,
Click here to add this to my saved trials
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
Epigenetic Factors Associated With Symptoms and Complications of Chronic Disorders
Status: Enrolling
Updated:  12/7/2015
Peninsula Cancer Institute
mi
from
Newport News, VA
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
Epigenetic Factors Associated With Symptoms and Complications of Chronic Disorders
Status: Enrolling
Updated: 12/7/2015
Peninsula Cancer Institute
mi
from
Newport News, VA
Click here to add this to my saved trials
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
Epigenetic Factors Associated With Symptoms and Complications of Chronic Disorders
Status: Enrolling
Updated:  12/7/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
Epigenetic Factors Associated With Symptoms and Complications of Chronic Disorders
Status: Enrolling
Updated: 12/7/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
Sarcoma Oncology Center
mi
from
Santa Monica, CA
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
Sarcoma Oncology Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
Washington Cancer Institute
mi
from
Washington,
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
Washington Cancer Institute
mi
from
Washington,
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
Kootenai Cancer Center
mi
from
Post Falls, ID
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
Kootenai Cancer Center
mi
from
Post Falls, ID
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
Oncology Specialists, S.C.
mi
from
Niles, IL
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
Oncology Specialists, S.C.
mi
from
Niles, IL
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
University of Iowa
mi
from
Iowa City, IA
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
Pennsylvania Oncology Hematology Associates
mi
from
Philadelphia, PA
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
Pennsylvania Oncology Hematology Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
The West Clinic, PC
mi
from
Memphis, TN
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated:  12/7/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Status: Enrolling
Updated: 12/7/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
Whole Body MRI for Detection of Cancer Metastases
Status: Enrolling
Updated:  12/7/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
Whole Body MRI for Detection of Cancer Metastases
Status: Enrolling
Updated: 12/7/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
Status: Enrolling
Updated:  12/7/2015
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Nashville, TN
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
Status: Enrolling
Updated: 12/7/2015
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Nashville, TN
Click here to add this to my saved trials
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
Status: Enrolling
Updated:  12/7/2015
Vanderbilt-Ingram Cancer Center at Franklin
mi
from
Nashville, TN
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
Status: Enrolling
Updated: 12/7/2015
Vanderbilt-Ingram Cancer Center at Franklin
mi
from
Nashville, TN
Click here to add this to my saved trials
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
Status: Enrolling
Updated:  12/7/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
Status: Enrolling
Updated: 12/7/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Pemetrexed for Second-Line Pancreas Cancer
A Phase II Study of Pemetrexed as Second-Line Treatment in Patients With Pancreatic Cancer Progressing Despite Therapy With Gemcitabine
Status: Enrolling
Updated:  12/7/2015
Georgetown University Hospital Lombardi Cancer Center
mi
from
Washington,
Study of Pemetrexed for Second-Line Pancreas Cancer
A Phase II Study of Pemetrexed as Second-Line Treatment in Patients With Pancreatic Cancer Progressing Despite Therapy With Gemcitabine
Status: Enrolling
Updated: 12/7/2015
Georgetown University Hospital Lombardi Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study
Assessment of Changes in Pattern and Magnitude of Tumor FDG Uptake During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer
Status: Enrolling
Updated:  12/7/2015
Washington University in St. Louis
mi
from
Saint Louis, MO
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study
Assessment of Changes in Pattern and Magnitude of Tumor FDG Uptake During Chemoradiation as a Predictor of Response to Concurrent Radiation Therapy and Chemotherapy in Patients With Cervical Cancer
Status: Enrolling
Updated: 12/7/2015
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)
Labeling of Receptor Ligands and Other Compounds With Halogen Radionuclides: Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using FFNP
Status: Enrolling
Updated:  12/7/2015
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)
Labeling of Receptor Ligands and Other Compounds With Halogen Radionuclides: Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using FFNP
Status: Enrolling
Updated: 12/7/2015
Washington University/ Barnes-Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Status: Enrolling
Updated:  12/8/2015
Duke Cancer Institute
mi
from
Durham, NC
Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Status: Enrolling
Updated: 12/8/2015
Duke Cancer Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated:  12/8/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated: 12/8/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated:  12/8/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated: 12/8/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated:  12/8/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated: 12/8/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated:  12/8/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
Status: Enrolling
Updated: 12/8/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Use of Multiphoton Microscopy in the Diagnosis of Cancer
Use of Multiphoton Microscopy in the Diagnosis of Cancer
Status: Enrolling
Updated:  12/8/2015
Weill-Cornell Medical College
mi
from
New York, NY
Use of Multiphoton Microscopy in the Diagnosis of Cancer
Use of Multiphoton Microscopy in the Diagnosis of Cancer
Status: Enrolling
Updated: 12/8/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
A Randomized, Double-blind, Placebo Controlled, Multi-center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked ( < 1 cm ) Epithelial Ovarian Cancer
Status: Enrolling
Updated:  12/8/2015
Providence Saint-Joseph Medical Center
mi
from
Burbank, CA
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
A Randomized, Double-blind, Placebo Controlled, Multi-center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked ( < 1 cm ) Epithelial Ovarian Cancer
Status: Enrolling
Updated: 12/8/2015
Providence Saint-Joseph Medical Center
mi
from
Burbank, CA
Click here to add this to my saved trials
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
A Randomized, Double-blind, Placebo Controlled, Multi-center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked ( < 1 cm ) Epithelial Ovarian Cancer
Status: Enrolling
Updated:  12/8/2015
UCLA
mi
from
Los Angeles, CA
Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
A Randomized, Double-blind, Placebo Controlled, Multi-center, Phase II Study of Adding AMG 479, a Fully Human Monoclonal Antibody Against Insulin-like Growth Factor Type 1 Receptor (IGF-1R) to First Line Chemotherapy in Patients With Optimally Debulked ( < 1 cm ) Epithelial Ovarian Cancer
Status: Enrolling
Updated: 12/8/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials